Rapid Developability Assessment of Early Phase Molecules: Parallel Screening of Enabling Technologies and Use of PBPK Modeling, Upcoming Webinar Hosted by Xtalks

Share Article

Join this free webinar to learn more about the benefits of using PBPK modeling, as well as the type of data needed to support a PBPK/DMPK evaluation. Other discussion points will include the red flags that signal the need for additional development studies and how a streamlined integrated program can accelerate early drug development.

Xtalks Life Science Webinars

This webinar will demonstrate how additional screening strategies can help you better understand your molecule and predict its future success on the path to commercialization.

Join Stephan Tindal, Director Science & Technology, Catalent Pharma Solutions and Jan Neelissen Ph.D., Scientific Advisor for PK/PD with PBPK Modeling, Science & Technology, Catalent Pharma Solutions in a live webinar on Wednesday, April 01, 2020 at 10am EDT (NA) (3pm BST/UK).

Achieving success in early development is essential in progressing to your molecule’s next milestone. While solving solubility is a major hurdle to overcome in early development, there are additional biopharmaceutical challenges to consider on the path to commercialization. This webinar will demonstrate how additional screening strategies can help you better understand your molecule and predict its future success on the path to commercialization.

Experts will highlight key screening strategies in early development that go beyond just solubility. The experts will review pre-formulation techniques and explain how they can accelerate early phase development to animal PK and first-in-human studies. This webinar will also explore the type of data collection needed to support PBPK/DMPK evaluations and the red flags in development that indicate the need for additional studies.

Lastly, the experts share a recent case study that illustrates how to use PBPK modeling, the developability classification system¹ and the biopharmaceutics drug distribution classification system² together to facilitate the development of a molecule.

For more information or to register for this event, visit Rapid Developability Assessment of Early Phase Molecules: Parallel Screening of Enabling Technologies and Use of PBPK Modeling.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mira Nabulsi
Xtalks
+1 (416) 977-6555 x 400
Email >
Visit website